Quidelortho Announces Availability Of QUICKVUETM Influenza + SARS Test For Professional Use
By Date,MENAFN
Copyright menafn
Key Features and Benefits:
Triple Detection Capability : Differentiates influenza A/B and COVID-19 in one test.
Fast Results : Clear results available in as fast as 10 minutes at the point of care.
Professional Use : Designed for CLIA-waived and moderate/high-complexity lab settings.
Efficient Workflow : Easy-to-collect nasal swab, streamlined processing and clear result window.
Affordable Access: Cost-effective visual combo test.
“Physician office labs and urgent care centers are on the front lines of respiratory illness diagnosis. With the QUICKVUE Influenza + SARS Test, we’re equipping healthcare providers with a reliable, affordable and efficient tool to differentiate between COVID-19 and influenza in minutes,” said Tammi Ranalli, PhD, Senior Vice President, Molecular Diagnostics and Point of Care Business Units, QuidelOrtho. “This innovation reflects QuidelOrtho’s commitment to supporting healthcare professionals with cost-effective solutions that streamline clinical decisions and help manage seasonal surges in respiratory infections.”
The launch of the QUICKVUE Influenza + SARS Test expands QuidelOrtho’s portfolio of respiratory solutions, including the SOFIATM 2 Flu + SARS Antigen FIA, by offering a visually read option alongside QuidelOrtho’s instrumented version and reinforces QuidelOrtho’s market leadership in point-of-care respiratory testing. The QUICKVUE Influenza + SARS Test is available in the United States through QuidelOrtho’s existing distribution channels and is not intended for in-home use.
About QuidelOrtho Corporation With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL ) is a leading global provider of diagnostic solutions, delivering fast, accurate and reliable results that help improve patient outcomes – from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.
For more information, visit and follow QuidelOrtho on LinkedIn, Facebook and X.
Investor Contact: Juliet CunninghamVice President, Investor Relations[email protected]
Media Contact: D. Nikki WheelerSenior Director, Corporate Communications[email protected]
SOURCE QuidelOrtho Corporation
